Rate My Professor Yet Hong Khor

Monash University

4.7

3 reviews · out of 5

Rate Yet

Is this you? Claim this profile

Ratings & reviews

5.08/20/2025

Encourages students to explore new ideas.

4.05/21/2025

Encourages students to think creatively.

5.04/30/2025

This comment is not public.

Taught by or worked with Yet?

Add your rating. It takes about 30 seconds.

About Yet

Associate Professor Yet Hong Khor is an Associate Professor (Research) in the School of Translational Medicine at Monash University, within the Faculty of Medicine, Nursing and Health Sciences. She holds clinical appointments as a Respiratory and Sleep Physician at Austin Health since 2015, an Interstitial Lung Disease (ILD) Specialist at Alfred Health since 2016, and Lead for the Oxygen Therapy Service at Austin Health since 2017. Her academic qualifications include a PhD in interstitial lung disease and oxygen therapy from the University of Melbourne, awarded in 2019, a Bachelor of Medicine/Bachelor of Surgery with First Class Honours from the University of Tasmania in 2007, and a Bachelor of Medical Science with Honours from the same university in 2005. Following her PhD, supported by an NHMRC Postgraduate Scholarship, she undertook a postdoctoral fellowship at the University of British Columbia, funded by an Australian Endeavour Leadership Award.

As an NHMRC Emerging Leadership Fellow, A/Prof Khor leads investigator-initiated research programs aimed at improving risk prediction, disease management, and patient outcomes in ILD and pulmonary fibrosis. Her research specializations include lung function trajectories in ILD, early diagnosis of lung fibrosis, oxygen therapy optimization, clinical trials, and qualitative evaluations of patient care. She ranks in the top 0.1% of ILD researchers and 0.4% of oxygen therapy researchers globally, according to Expertscape. Notable publications include 'Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement' (2025), 'Association of metformin with lung function decline and mortality in fibrotic interstitial lung disease: an observational cohort study' (2026), 'Nocturnal hypoxaemia in interstitial lung disease: a systematic review' (2021), 'Exertional Desaturation and Prescription of Ambulatory Oxygen Therapy in Interstitial Lung Disease' (2019), 'Effects of long-term oxygen therapy on acute exacerbation and mortality in interstitial lung disease' (2025), and 'Pulmonary Hypertension in Interstitial Lung Disease' (2024). She has secured competitive grants totaling nearly $1 million, primarily as principal investigator. Awards include the Austin Medical Research Foundation Bernie Sweet Clinical Research Fellowship (2021), American Thoracic Society travel awards (2019 and 2021), and the Lizotte Family Grant-in-Aid for Idiopathic Pulmonary Fibrosis. A/Prof Khor serves as Associate Editor for the European Respiratory Journal and Respirology Case Reports since 2020, and contributes to the Thoracic Society of Australia and New Zealand through roles such as steering committee member for the Education Hub (2022) and numerous symposium chairs and abstract review panels. She supervises physicians in training, honours, masters, and higher degree by research students, leading to their conference presentations and peer-reviewed publications.